HR1768-119

What This Bill Does

The Lower Costs for Everyday Americans Act is an omnibus bill spanning consumer products, technology, communications, health care, and public health. It directs EPA recycling and composting reports and a Recycling Infrastructure and Accessibility Program, permits year-round E15 fuel treatment, bans consumer products with high sodium nitrite concentrations, and requires CPSC battery standards. It makes the FCC publish foreign-owned authorization holders, creates Commerce supply-chain resilience and blockchain roles, creates a 6G task force, blocks certain untrusted satellite authorizations, and regulates nonconsensual intimate visual depictions through criminal, notice-and-removal, and FTC provisions. It adds vetting for universal service applicants, travel and tourism responsibilities, internet-connected device camera disclosures, semiconductor foreign direct investment coordination, hotel and short-term rental price advertising rules, event ticket refund requirements, and router/modem national-security studies. Large health titles streamline Medicaid and CHIP out-of-state provider enrollment, adjust home and community-based services, update Medicaid program integrity, pharmacy reimbursement, and spread pricing rules, extend Medicare telehealth, hospital-at-home, Part D antiviral, low-income outreach, multi-cancer screening, home infusion, pharmacy access, and provider directory provisions, and reauthorize or update substance-use, public-health emergency preparedness, wastewater surveillance, mosquito abatement, antimicrobial resistance, maternal health, sickle cell, Down syndrome, organ transplant, pediatric drug, rare disease voucher, orphan drug, FDA Abraham Accords, PBM oversight, rebate pass-through, and generic drug transparency provisions.

Who Benefits and How

Consumers benefit from product safety rules, hotel and ticket price transparency, camera disclosures, intimate-image takedown processes, and lower-cost health provisions. Patients and Medicare beneficiaries benefit from extended telehealth, hospital-at-home waivers, low-income Part D assistance, multi-cancer screening, home infusion, pharmacy choice, and public-health program reauthorizations. State Medicaid agencies benefit from clearer provider enrollment, home and community-based services, maternity cost reporting, DSH, pharmacy payment, and spread-pricing rules. Domestic technology and supply-chain companies benefit from Commerce, FCC, NTIA, blockchain, 6G, semiconductor, and trusted-network provisions. Generic drug applicants benefit from more FDA transparency around application deficiencies and patent litigation triggers.

Who Bears the Burden and How

Federal Trade Commission staff must enforce hotel-price, ticketing, connected-device, and platform notice-and-removal rules. Federal Communications Commission staff must publish foreign-ownership lists, run 6G work, and police untrusted satellite and universal service provisions. Department of Health and Human Services staff must implement extensive Medicaid, Medicare, public-health, FDA, PBM, and emergency-preparedness changes. Pharmacy benefit managers must meet oversight, rebate pass-through, and plan fiduciary obligations. Online platforms, device manufacturers, hotels, ticket sellers, and health plans face new disclosure, refund, takedown, reporting, and compliance duties.

Key Provisions

• Requires EPA recycling and composting reports and creates recycling infrastructure accessibility grants.
• Authorizes year-round E15 fuel treatment and bans high-concentration sodium nitrite consumer products.
• Creates FCC, Commerce, NTIA, blockchain, 6G, satellite-security, router-security, and semiconductor coordination duties.
• Requires consumer disclosures and protections for cameras in connected devices, hotel fees, ticket refunds, and nonconsensual intimate depictions.
• Extends or revises Medicaid, Medicare, Part D, telehealth, hospital-at-home, home infusion, pharmacy, and PBM provisions.
• Reauthorizes and updates public-health emergency, substance-use, maternal health, sickle cell, Down syndrome, organ transplant, pediatric drug, rare disease, and generic drug programs.